255 related articles for article (PubMed ID: 2322300)
1. Bioactivation of N-arylhydroxamic acids by rat hepatic N-acetyltransferase. Detection of multiple enzyme forms by mechanism-based inactivation.
Wick MJ; Hanna PE
Biochem Pharmacol; 1990 Mar; 39(6):991-1003. PubMed ID: 2322300
[TBL] [Abstract][Full Text] [Related]
2. N-acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes.
Smith TJ; Hanna PE
Carcinogenesis; 1986 May; 7(5):697-702. PubMed ID: 3486051
[TBL] [Abstract][Full Text] [Related]
3. An isozyme-selective affinity label for rat hepatic acetyltransferases.
Wick MJ; Yeh HM; Hanna PE
Biochem Pharmacol; 1990 Sep; 40(6):1389-98. PubMed ID: 2403393
[TBL] [Abstract][Full Text] [Related]
4. Hepatic N-acetyltransferases: selective inactivation in vivo by a carcinogenic N-arylhydroxamic acid.
Smith TJ; Hanna PE
Biochem Pharmacol; 1988 Feb; 37(3):427-34. PubMed ID: 3257389
[TBL] [Abstract][Full Text] [Related]
5. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
[TBL] [Abstract][Full Text] [Related]
6. Recombinant rat and hamster N-acetyltransferases-1 and -2: relative rates of N-acetylation of arylamines and N,O-acyltransfer with arylhydroxamic acids.
Jones RF; Land SJ; King CM
Carcinogenesis; 1996 Aug; 17(8):1729-33. PubMed ID: 8761433
[TBL] [Abstract][Full Text] [Related]
7. Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
Cheon HG; Boteju LW; Hanna PE
Mol Pharmacol; 1992 Jul; 42(1):82-93. PubMed ID: 1635555
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene.
Guo Z; Wagner CR; Hanna PE
Chem Res Toxicol; 2004 Mar; 17(3):275-86. PubMed ID: 15025497
[TBL] [Abstract][Full Text] [Related]
9. Effect of group-selective modification reagents on arylamine N-acetyltransferase activities.
Cheon HG; Hanna PE
Biochem Pharmacol; 1992 May; 43(10):2255-68. PubMed ID: 1599511
[TBL] [Abstract][Full Text] [Related]
10. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
Flammang TJ; Kadlubar FF
Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755
[TBL] [Abstract][Full Text] [Related]
11. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
12. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
[TBL] [Abstract][Full Text] [Related]
13. Monomorphic and polymorphic isozymes of arylamine N-acetyltransferases in hamster liver: purification of the isozymes and genetic basis of N-acetylation polymorphism.
Ozawa S; Abu-Zeid M; Kawakubo Y; Toyama S; Yamazoe Y; Kato R
Carcinogenesis; 1990 Dec; 11(12):2137-44. PubMed ID: 2265466
[TBL] [Abstract][Full Text] [Related]
14. Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase.
Mattano SS; Land S; King CM; Weber WW
Mol Pharmacol; 1989 May; 35(5):599-609. PubMed ID: 2725469
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hamster recombinant monomorphic and polymorphic arylamine N-acetyltransferases: bioactivation and mechanism-based inactivation studies with N-hydroxy-2-acetylaminofluorene.
Sticha KR; Bergstrom CP; Wagner CR; Hanna PE
Biochem Pharmacol; 1998 Jul; 56(1):47-59. PubMed ID: 9698088
[TBL] [Abstract][Full Text] [Related]
16. Irreversible inhibition of rat hepatic transacetylase activity by N-arylhydroxamic acids.
Wick MJ; Jantan IB; Hanna PE
Biochem Pharmacol; 1988 Apr; 37(7):1225-31. PubMed ID: 3355596
[TBL] [Abstract][Full Text] [Related]
17. Kinetic characterization of acetylator genotype-dependent and -independent N-acetyltransferase isozymes in homozygous rapid and slow acetylator inbred hamster liver cytosol.
Trinidad A; Kirlin WG; Ogolla F; Andrews AF; Yerokun T; Ferguson RJ; Brady PK; Hein DW
Drug Metab Dispos; 1989; 17(3):238-47. PubMed ID: 2568903
[TBL] [Abstract][Full Text] [Related]
18. The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster.
Hein DW; Kirlin WG; Ogolla F; Trinidad A; Thompson LK; Ferguson RJ
Drug Metab Dispos; 1986; 14(5):566-73. PubMed ID: 2876863
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of aromatic amines: relationships of N-acetylation, O-acetylation, N,O-acetyltransfer and deacetylation in human liver and urinary bladder.
Land SJ; Zukowski K; Lee MS; Debiec-Rychter M; King CM; Wang CY
Carcinogenesis; 1989 Apr; 10(4):727-31. PubMed ID: 2702722
[TBL] [Abstract][Full Text] [Related]
20. Properties of cutaneous acetyltransferase catalyzing N- and O-acetylation of carcinogenic arylamines and N-hydroxyarylamine.
Kawakubo Y; Manabe S; Yamazoe Y; Nishikawa T; Kato R
Biochem Pharmacol; 1988 Jan; 37(2):265-70. PubMed ID: 3342083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
